
IndraLab
Statements
Withanolide inhibits MAP3K7. 1 / 1
|
1
reach
"Chemokine receptor CCR7 is important for lymphatic invasion of cancer cells and is overexpressed in metastatic breast cancer cells; withanolide inhibits TAK1 to repress NF-kappaB-induced CCR7 expression in breast cancer cells and is useful for the prevention of lymphatic involvement by breast cancer cells [XREF_BIBR]."